1. Home
  2. MRVI vs UVV Comparison

MRVI vs UVV Comparison

Compare MRVI & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$7.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$45.96

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
UVV
Founded
2014
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
MRVI
UVV
Price
$7.72
$45.96
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
4.0M
303.7K
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
6.25%
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
$2,885,078,000.00
Revenue This Year
$12.54
$0.67
Revenue Next Year
$7.87
$0.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.29
$43.36
52 Week High
$9.42
$59.38

Technical Indicators

Market Signals
Indicator
MRVI
UVV
Relative Strength Index (RSI) 60.70 41.59
Support Level $5.37 $43.36
Resistance Level N/A $54.04
Average True Range (ATR) 0.51 1.04
MACD 0.20 0.22
Stochastic Oscillator 63.37 71.21

Price Performance

Historical Comparison
MRVI
UVV

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, the Philippines, Germany, and Other Countries, with the majority of revenue from the USA.

Share on Social Networks: